Dr. Johanna Scholz, Autor auf Euroimmun Blog https://www.euroimmunblog.com/author/johannafraune/ Forschung, Wissenschaft und Diagnostik Tue, 29 Jul 2025 13:51:05 +0000 en-US hourly 1 https://www.euroimmunblog.com/wp-content/uploads/2025/08/cropped-favicon_256x256-32x32.png Dr. Johanna Scholz, Autor auf Euroimmun Blog https://www.euroimmunblog.com/author/johannafraune/ 32 32 What you know and trust – now with a new shine https://www.euroimmunblog.com/euroimmun-rebranding/ https://www.euroimmunblog.com/euroimmun-rebranding/#respond Tue, 29 Jul 2025 13:51:05 +0000 https://www.euroimmunblog.de/?p=8899 Our new design is here!  Clearer, more modern, more international.   With our new design and visual language we have achieved a strong visual alignment with the corporate identity of Revvity, Inc. At the same time, we harmonized the visual appearance of the Euroimmun and IDS brands creating a new modernized look which visually reflects our shared identity and growing collaboration.  But what really counts remains the same: our […]

Der Beitrag What you know and trust – now with a new shine erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/euroimmun-rebranding/feed/ 0 What you know and trust – soon with a new shine https://www.euroimmunblog.com/what-you-know-and-trust-soon-with-a-new-shine/ https://www.euroimmunblog.com/what-you-know-and-trust-soon-with-a-new-shine/#respond Tue, 08 Jul 2025 09:30:07 +0000 https://www.euroimmunblog.de/?p=8773 Euroimmun is modernizing its brand appearance Our company has undergone significant developments in recent years. This will now also be reflected in our visual appearance. At the ADLM in Chicago (July 27–31, 2025), we will show you our new, modernized look for the first time, underlining our innovative power and our international orientation. But, of […]

Der Beitrag What you know and trust – soon with a new shine erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/what-you-know-and-trust-soon-with-a-new-shine/feed/ 0 Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay https://www.euroimmunblog.com/revvitys-euroimmun-receives-ce-mark-for-novel-measles-antibody-detection-assay/ https://www.euroimmunblog.com/revvitys-euroimmun-receives-ce-mark-for-novel-measles-antibody-detection-assay/#respond Mon, 03 Mar 2025 19:17:05 +0000 https://www.euroimmunblog.de/?p=8531 Press release, March 3rd 2025 Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus. EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding EUROIMMUN’s […]

Der Beitrag Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/revvitys-euroimmun-receives-ce-mark-for-novel-measles-antibody-detection-assay/feed/ 0 EUROArray SwiftX-traction: at high speed to isolated pathogen DNA https://www.euroimmunblog.com/euroarray-swiftx-traction-at-high-speed-to-isolated-pathogen-dna/ https://www.euroimmunblog.com/euroarray-swiftx-traction-at-high-speed-to-isolated-pathogen-dna/#respond Wed, 11 Dec 2024 11:32:23 +0000 https://www.euroimmunblog.de/?p=8356 At the end of last year, EUROIMMUN and Xpedite Diagnostics announced the start of a strategic partnership. Now the time has come: EUROArray SwiftX-traction is a rapid extraction procedure enabling the isolation of pathogen DNA for further analysis using EUROIMMUN’s EUROArrays. It has been especially developed for EUROIMMUN and is now approved worldwide for diagnostic […]

Der Beitrag EUROArray SwiftX-traction: at high speed to isolated pathogen DNA erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/euroarray-swiftx-traction-at-high-speed-to-isolated-pathogen-dna/feed/ 0 Revvity’s EUROIMMUN Launches Solution for Specific Typing of Alzheimer’s Disease Associated APOE Gene https://www.euroimmunblog.com/revvitys-euroimmun-launches-solution-for-specific-typing-of-alzheimers-disease-associated-apoe-gene/ https://www.euroimmunblog.com/revvitys-euroimmun-launches-solution-for-specific-typing-of-alzheimers-disease-associated-apoe-gene/#respond Wed, 02 Oct 2024 18:50:03 +0000 https://www.euroimmunblog.de/?p=8199 Press release October 2nd 2024 APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s Revvity, Inc. (NYSE: RVTY), announced today the launch of the in-vitro diagnostic assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene. APOE genotyping is […]

Der Beitrag Revvity’s EUROIMMUN Launches Solution for Specific Typing of Alzheimer’s Disease Associated APOE Gene erschien zuerst auf Euroimmun Blog.

]]> https://www.euroimmunblog.com/revvitys-euroimmun-launches-solution-for-specific-typing-of-alzheimers-disease-associated-apoe-gene/feed/ 0